The U.S. - EU "Framework for Advancing Transatlantic Economic Integration Between the United States of America and the European Union" for 2007 features QSAR methods for nanomaterials..
Strand Life Sciences announced that Gilead Sciences, Inc. has signed on as the first customer of Sarchitect - its SAR modelling and deployment platform. Sarchitect addresses the challenge of taking the model building prowess of computational chemists through to decision support in medicinal chemistry.
Scientists at the University at Buffalo's Institute for Lasers, Photonics and Biophotonics and Roswell Park Cancer Institute recently published research results about their innovative delivery system being the drug itself.
Applied Biosystems, MDS Sciex, Pfizer, and Sound Analytics will develop software to work with high-throughput automation technology to improve compound analysis.
Research and Markets has announced the addition of the Decision Resources, Inc. report: Repositioning ADME Studies: A Strategy to Reduce Drug Attrition to their offering.
On September 25th PETA donated $120,000 to the Duluth-based International QSAR Foundation to Reduce Animal Testing to save the lives of millions of animals routinely killed in laboratory experiments.
A group of Tripos senior executives will buy Tripos’s Discovery Research subsidiary for £548,000 ($1.1 million), according to a binding letter of intent (LoI) the company filed with the US Securities and Exchange commission on April 12, 2007.
Tripos declared it has closed the sale of its Discovery Informatics unit to Vector Capital for $26.2 million, and is still seeking a buyer for its Discovery Research business.
Affymetrix Inc. announced today that Robert P. Wayman, former executive vice president and chief financial officer at Hewlett-Packard, has been elected to the company's board of directors.
Neurogen Corporation, a small molecule drug discovery and development company, announces appointment of three executives to positions as vice president:
